Search Results

There are 21681 results for: content related to: IsoDGR-Tagged Albumin: A New αvβ3 Selective Carrier for Nanodrug Delivery to Tumors

  1. You have free access to this content
    Cilengitide downmodulates invasiveness and vasculogenic mimicry of neuropilin 1 expressing melanoma cells through the inhibition of αvβ5 integrin

    International Journal of Cancer

    Volume 136, Issue 6, 15 March 2015, Pages: E545–E558, Federica Ruffini, Grazia Graziani, Lauretta Levati, Lucio Tentori, Stefania D'Atri and Pedro M. Lacal

    Article first published online : 28 NOV 2014, DOI: 10.1002/ijc.29252

  2. Bimodal anti-glioma mechanisms of cilengitide demonstrated by novel invasive glioma models

    Neuropathology

    Volume 33, Issue 2, April 2013, Pages: 162–174, Manabu Onishi, Tomotsugu Ichikawa, Kazuhiko Kurozumi, Kentaro Fujii, Koichi Yoshida, Satoshi Inoue, Hiroyuki Michiue, E. Antonio Chiocca, Balveen Kaur and Isao Date

    Article first published online : 19 SEP 2012, DOI: 10.1111/j.1440-1789.2012.01344.x

  3. Conformational Control of Integrin-Subtype Selectivity in isoDGR Peptide Motifs: A Biological Switch

    Angewandte Chemie International Edition

    Volume 49, Issue 48, November 22, 2010, Pages: 9278–9281, Dr. Andreas O. Frank, Dipl.-Chem. Elke Otto, Dr. Carlos Mas-Moruno, Dr. Herbert B. Schiller, Prof. Dr. Luciana Marinelli, Dr. Sandro Cosconati, Dipl.-Chem. Alexander Bochen, Dr. Dörte Vossmeyer, Dr. Grit Zahn, Dr. Roland Stragies, Prof. Dr. Ettore Novellino and Prof. Dr. Horst Kessler

    Article first published online : 18 OCT 2010, DOI: 10.1002/anie.201004363

  4. Integrin Ligands with α/β-Hybrid Peptide Structure: Design, Bioactivity, and Conformational Aspects

    Medicinal Research Reviews

    Volume 36, Issue 3, May 2016, Pages: 389–424, Rossella De Marco, Alessandra Tolomelli, Eusebio Juaristi and Luca Gentilucci

    Article first published online : 18 JAN 2016, DOI: 10.1002/med.21383

  5. You have free access to this content
    The αVβ3/αVβ5 integrin inhibitor cilengitide augments tumor response to melphalan isolated limb perfusion in a sarcoma model

    International Journal of Cancer

    Volume 132, Issue 11, 1 June 2013, Pages: 2694–2704, Timo L.M. ten Hagen, Ann L.B. Seynhaeve, Gisela aan de Wiel-Ambagtsheer, Ernst A. de Bruijn, Sandra T. van Tiel, Curzio Ruegg, Michael Meyring, Matthias Grell, Simon L. Goodman and Alexander M.M. Eggermont

    Article first published online : 5 DEC 2012, DOI: 10.1002/ijc.27940

  6. You have free access to this content
    Pharmacological inhibition of integrin αvβ3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis

    Hepatology

    Volume 50, Issue 5, November 2009, Pages: 1501–1511, Eleonora Patsenker, Yury Popov, Felix Stickel, Vreni Schneider, Monika Ledermann, Hans Sägesser, Gerald Niedobitek, Simon L. Goodman and Detlef Schuppan

    Article first published online : 2 JUL 2009, DOI: 10.1002/hep.23144

  7. You have free access to this content
    Radiation sensitization of glioblastoma by cilengitide has unanticipated schedule-dependency

    International Journal of Cancer

    Volume 124, Issue 11, 1 June 2009, Pages: 2719–2727, Tom Mikkelsen, Chaya Brodie, Susan Finniss, Michael E. Berens, Jessica L. Rennert, Kevin Nelson, Nancy Lemke, Stephen L. Brown, Diane Hahn, Berend Neuteboom and Simon L. Goodman

    Article first published online : 23 DEC 2008, DOI: 10.1002/ijc.24240

  8. Metabolism and disposition of the αv-integrin ß3/ß5 receptor antagonist cilengitide, a cyclic polypeptide, in humans

    The Journal of Clinical Pharmacology

    Volume 55, Issue 7, July 2015, Pages: 815–824, Andreas Becker, Oliver von Richter, Andreas Kovar, Holger Scheible, Jan J. van Lier and Andreas Johne

    Article first published online : 23 MAR 2015, DOI: 10.1002/jcph.482

  9. You have free access to this content
    αv-Integrin isoform expression in primary human tumors and brain metastases

    International Journal of Cancer

    Volume 133, Issue 10, 15 November 2013, Pages: 2362–2371, Alexander Vogetseder, Svenja Thies, Barbara Ingold, Patrick Roth, Michael Weller, Peter Schraml, Simon L. Goodman and Holger Moch

    Article first published online : 10 JUN 2013, DOI: 10.1002/ijc.28267

  10. Receptor-Bound Conformation of Cilengitide Better Represented by Its Solution-State Structure than the Solid-State Structure

    Chemistry - A European Journal

    Volume 20, Issue 44, October 27, 2014, Pages: 14201–14206, Dr. Udaya Kiran Marelli, Dr. Andreas O. Frank, Dr. Bernhard Wahl, Dr. Valeria La Pietra, Prof. Ettore Novellino, Dr. Luciana Marinelli, Dr. Eberhardt Herdtweck, Prof. Dr. Michael Groll and Prof. Dr. Horst Kessler

    Article first published online : 22 SEP 2014, DOI: 10.1002/chem.201403839

  11. Konformative Kontrolle über Integrin-Subtyp-Selektivitäten in isoDGR-Peptidmotiven: ein biologischer Schalter

    Angewandte Chemie

    Volume 122, Issue 48, November 22, 2010, Pages: 9465–9468, Dr. Andreas O. Frank, Dipl.-Chem. Elke Otto, Dr. Carlos Mas-Moruno, Dr. Herbert B. Schiller, Prof. Dr. Luciana Marinelli, Dr. Sandro Cosconati, Dipl.-Chem. Alexander Bochen, Dr. Dörte Vossmeyer, Dr. Grit Zahn, Dr. Roland Stragies, Prof. Dr. Ettore Novellino and Prof. Dr. Horst Kessler

    Article first published online : 18 OCT 2010, DOI: 10.1002/ange.201004363

  12. Cyclic isoDGR and RGD Peptidomimetics Containing Bifunctional Diketopiperazine Scaffolds are Integrin Antagonists

    Chemistry - A European Journal

    Volume 21, Issue 16, April 13, 2015, Pages: 6265–6271, Silvia Panzeri, Simone Zanella, Dr. Daniela Arosio, Leila Vahdati, Alberto Dal Corso, Dr. Luca Pignataro, Dr. Mayra Paolillo, Prof. Dr. Sergio Schinelli, Prof. Dr. Laura Belvisi, Prof. Dr. Cesare Gennari and Prof. Dr. Umberto Piarulli

    Article first published online : 11 MAR 2015, DOI: 10.1002/chem.201406567

  13. You have free access to this content
    Combination therapy of cilengitide with belotecan against experimental glioblastoma

    International Journal of Cancer

    Volume 133, Issue 3, 1 August 2013, Pages: 749–756, Young-Hoon Kim, Jin Kyung Lee, Bokyong Kim, Judy Park DeWitt, Jung Eun Lee, Jung Ho Han, Seung-Ki Kim, Chang Wan Oh and Chae-Yong Kim

    Article first published online : 27 FEB 2013, DOI: 10.1002/ijc.28058

  14. Erhöhung der αvβ3-Selektivität des Angiogenese hemmenden Wirkstoffs Cilengitid durch N-Methylierung

    Angewandte Chemie

    Volume 123, Issue 40, September 26, 2011, Pages: 9668–9672, Dr. Carlos Mas-Moruno, Johannes G. Beck, Dr. Lucas Doedens, Dr. Andreas O. Frank, Prof. Dr. Luciana Marinelli, Dr. Sandro Cosconati, Prof. Dr. Ettore Novellino and Prof. Dr. Horst Kessler

    Article first published online : 25 AUG 2011, DOI: 10.1002/ange.201102971

  15. Increasing αvβ3 Selectivity of the Anti-Angiogenic Drug Cilengitide by N-Methylation

    Angewandte Chemie International Edition

    Volume 50, Issue 40, September 26, 2011, Pages: 9496–9500, Dr. Carlos Mas-Moruno, Johannes G. Beck, Dr. Lucas Doedens, Dr. Andreas O. Frank, Prof. Dr. Luciana Marinelli, Dr. Sandro Cosconati, Prof. Dr. Ettore Novellino and Prof. Dr. Horst Kessler

    Article first published online : 25 AUG 2011, DOI: 10.1002/anie.201102971

  16. Kleine Ursache, große Wirkung: Modifikation der Guanidiniumgruppe im RGD-Motiv reguliert die Integrinsubtypselektivität

    Angewandte Chemie

    Volume 128, Issue 4, January 22, 2016, Pages: 1564–1568, Tobias G. Kapp, Maximilian Fottner, Dr. Oleg V. Maltsev and Prof. Dr. Horst Kessler

    Article first published online : 9 DEC 2015, DOI: 10.1002/ange.201508713

  17. Small Cause, Great Impact: Modification of the Guanidine Group in the RGD Motif Controls Integrin Subtype Selectivity

    Angewandte Chemie International Edition

    Volume 55, Issue 4, January 22, 2016, Pages: 1540–1543, Tobias G. Kapp, Maximilian Fottner, Dr. Oleg V. Maltsev and Prof. Dr. Horst Kessler

    Article first published online : 9 DEC 2015, DOI: 10.1002/anie.201508713

  18. You have free access to this content
    A safety run-in and randomized phase 2 study of cilengitide combined with chemoradiation for newly diagnosed glioblastoma (NABTT 0306)

    Cancer

    Volume 118, Issue 22, 15 November 2012, Pages: 5601–5607, L. Burt Nabors, Thomas Mikkelsen, Monika E. Hegi, Xiaubu Ye, Tracy Batchelor, Glenn Lesser, David Peereboom, Myrna R. Rosenfeld, Jeff Olsen, Steve Brem, Joy D. Fisher, Stuart A. Grossman and for the New Approaches to Brain Tumor Therapy (NABTT) Central Nervous System Consortium

    Article first published online : 19 APR 2012, DOI: 10.1002/cncr.27585

  19. Population pharmacokinetics of cilengitide in adult and pediatric cancer patients from a nonlinear mixed-effects analysis

    The Journal of Clinical Pharmacology

    Volume 54, Issue 12, December 2014, Pages: 1391–1399, Michael Zühlsdorf, Venkatesh Atul Bhattaram, Marco Campioni, Sonja Krösser, Hartmut Derendorf and Andreas Kovar

    Article first published online : 26 JUN 2014, DOI: 10.1002/jcph.343

  20. Behavior of primary human osteoblasts on trimmed and sandblasted Ti6Al4V surfaces functionalized with integrin αvβ3-selective cyclic RGD peptides

    Journal of Biomedical Materials Research Part A

    Volume 101A, Issue 1, January 2013, Pages: 87–97, Carlos Mas-Moruno, Petra M. Dorfner, Florian Manzenrieder, Stefanie Neubauer, Ute Reuning, Rainer Burgkart and Horst Kessler

    Article first published online : 24 JUL 2012, DOI: 10.1002/jbm.a.34303